To investigate the impact of METTL3 expression on the prognosis of pancreatic cancer patients, we utilized the PanCanSurvPlot database and observed that patients with high METTL3 expression exhibited a poor prognosis (Fig. 1A). This evidence concerns the gene METTL3 and familial pancreatic carcinoma.